Implementation Study of Patient-Ready Syringes Containing 25 mg/mL Methotrexate Solution for Use in Treating Ectopic Pregnancy

Background. Ectopic pregnancy (EP) is a significant cause of morbidity and mortality during the first trimester of pregnancy. Small unruptured tubal pregnancies can be treated medically with a single dose of methotrexate (MTX). Objective. The aim of this study was to evaluate the stability of a 25 m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Respaud, R., Gaudy, A. S., Arlicot, C., Tournamille, J. F., Viaud-Massuard, M. C., Elfakir, C., Antier, D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2014
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4037123/
https://ncbi.nlm.nih.gov/pubmed/24900977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/689308
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak